This inventor holds 1 USPTO granted patent. Top assignee: Kashiv Biosciences, LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Parth Hitarthbhai Vaishnav: Biopharmaceutical Process Innovation
Introduction
Parth Hitarthbhai Vaishnav is an inventor associated with Jamnagar, India, and Kashiv Biosciences, LLC. His patent work concerns improving the production of omalizumab, an anti-IgE antibody, in mammalian cell culture. His listed portfolio includes 1 patent.
Latest Patents
Vaishnav’s patent, “Process for Improving Omalizumab Expression in CHO Cells,” describes a method intended to improve antibody production titer while reducing galactosylation and/or acidic variants. The disclosed process uses suitable mammalian cell-culture conditions, including fed-batch operation, and maintains the culture at 36.5°C ± 0.5°C throughout its duration.
Career Highlights
The patent reflects work on optimizing the expression and product characteristics of a therapeutic antibody in Chinese hamster ovary (CHO) cells. Such process improvements can support the development and manufacture of biologic medicines.
Collaborations
The supplied information identifies Kaumil Bhupendra Bhai Bhavsar and Ghanshyam Madhabhai Patel as Vaishnav’s coworkers. The patent is associated with Kashiv Biosciences, LLC.
Conclusion
Parth Hitarthbhai Vaishnav’s patent focuses on improving omalizumab production in CHO-cell culture through controlled process conditions, highlighting his contribution to biopharmaceutical manufacturing innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile